GRAIL, Inc. Class Action Lawsuit

Company: GRAIL, Inc.

Ticker: (NASDAQ) GRAL

Class Action Period: May 13, 2025 - February 19, 2026

52 Days LeftLead Plaintiff Deadline: August 4, 2026

See If You Qualify For Monetary Reward

Join the GRAIL, Inc. Class Action Lawsuit

There is no cost or obligation for you to submit.

The submission of this form does not create an attorney-client relationship.

CLASS ACTION PERIOD

May 13, 2025 - February 19, 2026

Allegations

Allegations

According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of GRAIL’s NHS-Galleri trial following the reveal of the top-line results covering the first screening round. Notably, as defendants have since attested, the trial as executed within the three-year follow-up period was insufficient to demonstrate the achievability of a reduction in Stage III-IV cancers; defendants disclosed the trial period, and thus the screening duration, was apparently insufficient to demonstrate whether the primary endpoint was achievable. Defendants further repeatedly refused to provide detailed topline results or other data from the NHS-Galleri study, potentially concealing known trendlines which arguably suggested either a longer timeline would be necessary or otherwise that the probability of achieving the statistical reduction in Stage III & IV cancers by the trial’s end had been reduced. On February 19, 2026, GRAIL announced that the “primary endpoint of statistically significant Stage III-IV reduction was not observed” in the NHS-Galleri Trial. The Company attributed this shortcoming, in part, on “probably need[ing] a longer follow-up time to be able to [compare the study arms] adequately.” Following this news, the price of GRAIL’s common stock declined dramatically. From a closing market price of $101.53 per share on February 19, 2026, Grail’s stock price fell to $50.21 per share on February 20, 2026, a decline of about 50.55% in the span of just a single day.

Eligibility

Eligibility

To join the lawsuit, you must have experienced a loss on GRAIL shares purchased within the class period specified above.

Lead Plaintiff Deadline

Lead Plaintiff Deadline

If you suffered a loss in GRAIL during the relevant time frame or pursuant to the relevant offering(s), you have until August 4, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Frequently Asked Questions

How do I join the lawsuit against GRAIL, Inc. (NASDAQ: GRAL)?

Investors who purchased shares of GRAIL, Inc. (NASDAQ: GRAL) during the class period (May 13, 2025 - February 19, 2026) can join by submitting their transaction details through this case page.

  • Ensure your purchase falls within the class period
  • Provide basic transaction and loss details
  • Submit your information before the deadline

The lead plaintiff deadline for this case is August 4, 2026, so investors should act quickly to protect their rights.

Who is eligible for the GRAIL, Inc. lawsuit?

Anyone who bought shares of GRAIL, Inc. (NASDAQ: GRAL) during May 13, 2025 - February 19, 2026 and suffered financial losses may qualify.

What is the lead plaintiff deadline to join the GRAIL, Inc. case?

The lead plaintiff deadline for the GRAIL, Inc. lawsuit is August 4, 2026. Investors should act quickly to avoid missing this deadline.

What is the class period for GRAIL, Inc.?

The class period for GRAIL, Inc. (NASDAQ: GRAL) is May 13, 2025 - February 19, 2026, during which investors may have been affected by alleged misconduct.

Can I still join the GRAIL, Inc. lawsuit if I sold my shares?

Yes. Investors who purchased GRAIL, Inc. shares during May 13, 2025 - February 19, 2026 may still qualify, even if they sold their shares later.

How much compensation can I receive from the GRAIL, Inc. lawsuit?

Compensation depends on the total losses and the final settlement. Eligible investors in the GRAIL, Inc. case may receive a portion of the recovery.

Do I need to pay to participate in the GRAIL, Inc. case?

No, most securities fraud cases involving GRAIL, Inc. operate on a contingency basis, meaning there are no upfront costs unless there is a recovery.

Will I need to appear in court for the GRAIL, Inc. lawsuit?

In most cases, investors do not need to appear in court. The legal team manages the GRAIL, Inc. case on behalf of participants.

What documents are required for the GRAIL, Inc. lawsuit?

To participate in the GRAIL, Inc. lawsuit, investors may need to provide transaction records, purchase dates, number of shares, and loss details.

What happens after I submit my trade information for GRAIL, Inc.?

After submission, your details for the GRAIL, Inc. case will be reviewed, and you may be contacted regarding eligibility or next steps.

Is this legal advice for the GRAIL, Inc. lawsuit?

No, this page provides information about the GRAIL, Inc. case and does not constitute legal advice or create an attorney-client relationship.

Why should I act quickly on the GRAIL, Inc. case?

The lead plaintiff deadline for the GRAIL, Inc. lawsuit is August 4, 2026. If you are an investor, you may have the opportunity to seek appointment as lead plaintiff or remain an absent class member.

EXPLORE MORE CASES

Badger Meter, Inc.

BMI

Lead Plaintiff Deadline: August 3, 2026

Class Period: April 18, 2024 - April 16, 2026

51 Days Left

FS KKR Capital Corp

FSK

FS KKR Capital Corp. (FSK) Securities Class Action Lawsuit Update

Lead Plaintiff Deadline: July 6, 2026

Class Period: May 8, 2024 - February 25, 2026

23 Days Left

Phreesia, Inc.

PHR

Phreesia, Inc. (PHR) Securities Class Action Lawsuit Update

Lead Plaintiff Deadline: July 13, 2026

Class Period: May 8, 2025 - March 30, 2026

30 Days Left

Case Podcast